Todos os Artigos

1.236 artigos

Scientists Switch On Nerve Regeneration Once Thought Lost Forever
Brain Health

Scientists Switch On Nerve Regeneration Once Thought Lost Forever

Cambridge researchers found a gene network that shuts off nerve repair — and an existing hormone drug that reactivates it.

Comunicado de Imprensa
29 de mai. de 2026 0
Why Consumer DNA Health Tests May Be Misleading You About Real Disease Risk
Nutrition & Diet

Why Consumer DNA Health Tests May Be Misleading You About Real Disease Risk

Genetic testing for health risks has a 40% false-positive rate and often outperformed by lifestyle factors. Here's what the evidence shows.

Comunicado de Imprensa
29 de mai. de 2026 0
New Hep B Drug Achieves Functional Cure in 1 in 5 Patients in Phase III Trials
Longevity & Aging

New Hep B Drug Achieves Functional Cure in 1 in 5 Patients in Phase III Trials

Bepirovirsen, an antisense oligonucleotide, delivered functional cures in ~20% of chronic hepatitis B patients — a landmark leap over existing therapies.

Comunicado de Imprensa
29 de mai. de 2026 0
One Bad Sunburn Can Trigger DNA Mutations That Build Toward Skin Cancer
Longevity & Aging

One Bad Sunburn Can Trigger DNA Mutations That Build Toward Skin Cancer

Dermatologists explain how UV damage accumulates over time, why repair mechanisms matter, and what actually drives skin cancer risk.

Comunicado de Imprensa
29 de mai. de 2026 0
Trouble Hearing in Noisy Rooms May Signal Early Brain Aging Before Dementia Appears
Longevity & Aging

Trouble Hearing in Noisy Rooms May Signal Early Brain Aging Before Dementia Appears

Struggling to follow conversations at parties may reflect faster brain thinning in key cognitive regions, even before cognitive decline shows up on tests.

Comunicado de Imprensa
29 de mai. de 2026 0
FDA Approves First New Bladder Cancer Therapy in 30 Years Using Immune Checkpoint Combo
Longevity & Aging

FDA Approves First New Bladder Cancer Therapy in 30 Years Using Immune Checkpoint Combo

Durvalumab plus BCG cuts recurrence risk by nearly a third in high-risk bladder cancer patients, marking a major treatment milestone.

Comunicado de Imprensa
29 de mai. de 2026 0
Alzheimer's Pathology Detected in Midlife Brains Decades Before Symptoms Appear
Longevity & Aging

Alzheimer's Pathology Detected in Midlife Brains Decades Before Symptoms Appear

A landmark study finds Alzheimer's biomarkers in 6% of middle-aged adults, predicting steep cognitive decline within 5 years.

Comunicado de Imprensa
29 de mai. de 2026 0
CBD May Fight Alzheimer's by Cooling Brain Inflammation in Mouse Study
Longevity & Aging

CBD May Fight Alzheimer's by Cooling Brain Inflammation in Mouse Study

New research shows inhaled CBD reduces neuroinflammation in Alzheimer's mice, suggesting a multi-target therapeutic approach to the disease.

Comunicado de Imprensa
29 de mai. de 2026 0
How Early Cancer Cells Hijack Healthy Tissue to Build Their Own Growth Environment
Longevity & Aging

How Early Cancer Cells Hijack Healthy Tissue to Build Their Own Growth Environment

New research reveals how mutant lung cells reprogram surrounding tissue into a tumor-friendly niche — before cancer is even detectable.

Comunicado de Imprensa
29 de mai. de 2026 0
New AI Algorithm Predicts How Genes Respond to Treatments With Record Accuracy
Longevity & Aging

New AI Algorithm Predicts How Genes Respond to Treatments With Record Accuracy

Altos Labs' PRiMeFlow algorithm predicts cellular gene expression changes from interventions, outperforming rivals on key benchmarks.

Comunicado de Imprensa
29 de mai. de 2026 0
AI Giants Team Up to Catch Age-Related Disease Before It Starts
Longevity & Aging

AI Giants Team Up to Catch Age-Related Disease Before It Starts

Insilico Medicine and Human Longevity's HLFM merge AI muscle with decade-long multi-omic data to predict and prevent age-related disease.

Comunicado de Imprensa
29 de mai. de 2026 0
Therini Bio Trials New Eye Injection That Targets Both Fibrin and VEGF in Diabetic Patients
Longevity & Aging

Therini Bio Trials New Eye Injection That Targets Both Fibrin and VEGF in Diabetic Patients

A novel antibody targeting inflammation in diabetic eye disease enters Phase 1b trials, with early data expected by end of 2026.

Comunicado de Imprensa
29 de mai. de 2026 0
AnteriorPágina 29 de 103Próximo